猫围喷液-一个糟糕的预后?
Laura Letwin1, Sivert Nerhagen2, Camilla Hindar2
1AURA Veterinary, 70 Priestley Road, Guildford GU27AJ, UK.
Animals : an open access journal from MDPI
|November 27, 2025
概括
猫炎的预后有所改善,有55%的猫活了下来. 尿皮质提供了最好的生存率,而血皮质的生存率最低,这突显了猫炎结果中溢出原因的重要性.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 内部医学 内部医学
- 诊断成像 诊断成像 诊断成像
背景情况:
- 从历史上看,猫风的预后很差,最近关于所有病因的生存数据有限.
- 关于猫炎预后的先前研究涉及小患者队列,需要更新研究.
研究的目的:
- 为了评估一大群患有风的猫科动物的生存时间.
- 为了确定流血原因,患者信号,临床病理学和成像发现对生存的影响.
主要方法:
- 从转诊医院的医疗记录的回顾性分析.
- 包括498只患有风的猫,分析存活到出院的时间和出院后的中位生存时间.
- 对影响生存的因素的统计评估,包括图像成像上的输出病因和主观输出量.
主要成果:
- 55%的猫活到出院,出院后平均存活时间为30.5天.
- 输出导致显著影响生存率 (p = 0.002),尿 (77%的存活率) 比血 (40%的存活率) 更好.
- 对成像的主观输出量评估也与生存率有显著的相关性 (p = 0.012).
结论:
- 猫炎的预后受到喷液病因和体积的影响,更简单的诊断评估提供了有价值的预后信息.
- 尿和血代表猫中不同的预后类别.
- 这项研究为患有炎的大型猫种群提供了最新的预后数据.
相关概念视频
Pleural Effusion II: Symptoms and Management
614
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
614
Pericarditis III: Medical Management
290
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
290
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
498
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
498
Pleural Effusion I: Introduction
3.8K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
3.8K
Pericarditis II: Clinical Features and Diagnostic Tests
270
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
270
Esophageal Perforation-II: Clinical Manifestations and Management
472
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
472


